Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Spring 2018 - Safety
Download Issue
Share
Up Front
Publisher's Corner
Our Commitment to Safety
By Patrick M. Schmidt
Features
The Evolution of Medical Aid in Dying
By
Diane L.M. Cook
Myths and Facts: Cataracts
By
Ronale Tucker Rhodes, MS
Healthcare Data: Ensuring Regulatory Compliance
By
Amy Scanlin, MS
Banishing Burnout in Healthcare Settings
By
Trudie Mitschang
Are Drugs Really Overpriced?
By
Meredith Whitmore
BioTrends Watch
Washington Report
CMS Finalizes Medicare Advantage Rates for 2019
Work Requirements Can Be Used as a Basis for Medicaid Eligibility
New Policy Guidance Issued to Improve Medicaid Beneficiary Enrollment
HHS Forms Conscience and Religious Freedom Division
New Secretary of Health and Human Services Confirmed
CMS Launches Voluntary Bundled Payment Model
Hike Proposed for Medicare Payments in 2019
Reimbursement FAQs
Basic Concepts Driving Drug Payment
Avoiding Part B Reimbursement Pitfalls
Industry News
CDC OKs FluMist for 2018-19 Influenza Season
FDA Approves First Biosimilar to Fight Cancer
First Treatment Approved by FDA to Treat EGPA
Influenza Vaccine Coverage Is Highest Among Workplaces with Vaccination Requirements
New Pill May Kill the Flu Virus in Patients in 24 Hours
Higher-Potency Rabies IG Vaccine Receives FDA Approval
Medicare Costs Pose Rising Financial Burden on Older Adults
Mylan’s Ogivri Approved as Biosimilar to Herceptin
Study Finds 2017-18 Flu Vaccine More Protective Than Believed, Especially Among Children
Universal Flu Vaccine Begins Two-Year Clinical Trial
Study Shows Fever During Pregnancy Increases Risk of Autism at Birth
First Digital Pill for Mental Illness Approved by FDA
FDA Issues Product Advisory for CSL Behring's AlbuRx
Study Finds Antibiotics Can Weaken the Immune System
Study Shows Antabuse Lowers Risk of Death from Cancer
BioFocus
Industry Insight
Gene Therapy for Hemophilia: Edging Closer to Reality
By Keith Berman, MPH, MBA
Patient Profile
Necrotizing Fasciitis: A Patient's Perspective
By Trudie Mitschang
Disease Profile
Flesh-Eating Bacteria: Fear vs. Facts
By Trudie Mitschang
BioSources
BioResearch
Plasma Exchange with 5% Albumin Associated with Marked Stabilization of Brain Perfusion in Alzheimer’s
Subcutaneous Immune Globulin Effective as Maintenance Treatment in Chronic Inflammatory Demyelinating Polyneuropathy